Isoniazid preventive therapy for HIV-infected people: evidence to support implementation

From:
Department for International Development
Published
1 January 2010
Document Type:
Journal Article
Theme:
Health
Authors:
Churchyard, G., Grant, A.D., Chaisson, R.E., Getahun, H., Durovni, B., Eldred, L.J. and Godfrey-Faussett, P.

Abstract

It is argued that isoniazid is beneficial to reduce TB risk in people with HIV infections.

Citation

Eldred, L.J.; Churchyard, G.; Durovni, B.; Godfrey-Faussett, P.; Grant, A.D.; Getahun, H.; Chaisson, R.E. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation. AIDS (2010) 24 (Suppl 5) S1-S3. [DOI: 10.1097/01.aids.0000391009.95149.ec]

Isoniazid preventive therapy for HIV-infected people: evidence to support implementation

Updates to this page

Published 1 January 2010
Contents